FDA — authorised 30 March 1982
- Application: NDA018029
- Marketing authorisation holder: NOVARTIS
- Local brand name: RITALIN-SR
- Indication: TABLET, EXTENDED RELEASE — ORAL
- Status: approved
FDA authorised Ritalin-SR on 30 March 1982
Yes. FDA authorised it on 30 March 1982.
NOVARTIS holds the US marketing authorisation.